ACRE Publications

Access book chapters, journal articles, editorials and commentaries, and reports contributed to and produced by ACRE investigators and members. 

 

Book chapters

 

W Hall. Cannabis and cannabinoids for medical, scientific and 'recreational' use: risks and benefits. INCB Report 2018.[Full text]

 

Journal articles

N Solowij, S Broyd, L Greenwood, H van Hell, D Martelozzo, K Rueb, J Todd, Z Liu, P Galettis, J Martin, R Murray, A Jones, P Michie and R Croft. A randomised controlled trial of vaporised Δ9-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute intoxication effects. European Archives of Psychiatry and Clinical Neuroscience. February 2019, Volume 269, Issue 1, pp 17-35. [Full text]

 

N Solowij. Peering Through the Haze of Smoked vs Vaporized Cannabis—To Vape or Not to Vape? The Journal of the American Medical Association (JAMA Network). JAMA Netw Open. 2018;1(7):e184838. November 30, 2018. [Full text]

 

C Lucas, P Galettis and J Schneider. The pharmacokinetics and the pharmacodynamics of cannabinoids. British Journal of Clinical Pharmacology. Br J Clin Pharmacol. 2018 Nov;84 (11):2477-2482. doi: 10.1111/bcp.13710. Epub 2018 Aug 7. [Full text]

 

Y Bonomo, J Souza, A Jackson J Crippa, N Solowij. Clinical issues in cannabis use. British Journal of Clinical Pharmacology. Br J Clin Pharmacol. 2018 Nov;84(11):2495-2498. doi: 10.1111/bcp.13703. Epub 2018 Aug 2017. [Full text]

 

Z Liu and J Martin. Gaps in predicting clinical doses for cannabinoids therapy: Overview of issues for pharmacokinetics and pharmacodynamics modelling. British Journal of Clinical Pharmacology. Br J Clin Pharmacol. 2018 Nov;84 (11):2483-2487. doi: 10.1111/bcp.13635. Epub 2018 Jun 7. [Full text]

 

L Dryburgh, N Bolan, C Grof, P Galettis, J Schneider, C Lucas and J Martin. Cannabis contaminants: sources, distribution, human toxicity and pharmacologic effects. British Journal of Clinical Pharmacology. Br J Clin Pharmacol. 2018 Nov;84(11):2468-2476. doi: 10.1111/bcp.13695. Epub 2018 Aug 1. [Full text]

 

C Grof. Cannabis, from plant to pill. British Journal of Clinical Pharmacology. Br J Clin Pharmacol. 2018 Nov;84(11):2463-2467. doi: 10.1111/bcp.13618. Epub 2018 May 24. [Full text]

 

J Martin and Noel Cranswick. Care and concern with cannabinoids used therapeutically. British Journal of Clinical Pharmacology. Br J Clin Pharmacol. 2018 Nov;84(11):2455-2457. doi: 10.1111/bcp.13724. Epub 2018 Aug 22. [Full text]

 

J Martin, Y Bonomo and A Reynolds. Compassion and evidence in prescribing cannabinoids: a perspective from the Royal Australasian College of Physicians. The Medical Journal of Australia. Med J Aust 2018; 208 (3): 107-109. || doi: 10.5694/mja17.01004. [Full text]

 

W Hall and M Farrell. The challenges in providing safe, effective, affordable cannabis-based medicines for unapproved indications. The Medical Journal of Australia. Med J Aust 2018; 209 (5): 209-210. || doi: 10.5694/mja18.00445. [Full text]

 

C Lucas, P Galettis, S Song, N Reuter, J Schneider and J Martin. Cannabinoid disposition after human intraperitoneal use: an insight into intraperitoneal pharmacokinetic properties in metastatic cancer. Clinical Therapeutics 2018;40(9):1442-1447.  [Full text]

 

J Martin, J Schneider, C Lucas and P Galettis. Exogenous Cannabinoid Efficacy: Merely a Pharmacokinetic Interaction? Clinical Pharmacokinetics 2018;57(5):529545.  [Full text]

 

C Lucas and J Martin. Predicting Drug Interactions in Addiction Treatment. Internal Medicine Journal 2017;47(8):872-878.  [Full text]

 

Editorials and commentaries

 

J Martin and N Talley. Cannabinoid use in practice in Australasia - better guidance and new drug information systems will be essential for prescribers. British Journal of Clinical Pharmacology. April 2019. [Full text]

 

J Martin. Australia building the evidence based on medical cannabinoids. Health Europa. April 2019. [Full text]

 

J Martin. Yes we cannabis? High stakes for medical professionals, politicians and the community. Asia and the Pacific Policy Society Policy Forum. [Full text]

 

W Hall. Medicinal cannabis should be more than pot luck: How can cannabis-based medicines be made safe, effective, and affordable? Asia and the Pacific Policy Society Policy Forum. [Full text]

 

Reports

 

W Hall. Medical Use of Cannabis and Cannabinoids: Questions and Answers for Policymaking. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). [Full text]

ACRE • All Right Reserved

Website by mudbath